Founded in Minnesota, SynerFuse is a medical device company dedicated to innovating the spine industry. Their core mission is to provide long-term pain management solutions without relying on addictive opioids. The company's flagship product, the patented Electric Transforaminal Lumbar Interbody Fusion (e-TLIF™) procedure, integrates spinal fusion with direct nerve stimulation to address chronic lower back pain effectively. SynerFuse primarily focuses on the healthcare market, targeting patients suffering from chronic back pain.
SynerFuse has garnered attention from notable figures in the medical and investment communities. The company's innovative approach has led to significant achievements, including successful clinical trials and growing adoption of their e-TLIF™ procedure. Their impact is evident in the improved quality of life for patients who have undergone their treatments, positioning SynerFuse as a transformative player in the field of pain management and spinal health.
